paclitaxel 260 mg
paclitaxel 260 mg

paclitaxel 260 mg

Price 420.0 INR/ Number

paclitaxel 260 mg Specification

  • Indication
  • Used for the treatment of ovarian cancer, breast cancer, and non-small cell lung cancer
  • Dosage Form
  • Injection
  • Salt Composition
  • Paclitaxel 260 mg
  • Feature
  • Sterile, single use, cytotoxic
  • Ingredients
  • Paclitaxel, Cremophor EL, Ethanol
  • Application
  • Ph Level
  • pH 3.0 - 4.0
  • Physical Color/Texture
  • Clear, colorless to pale yellow solution
  • Storage Instructions
  • Store below 25C, protect from light
  • Shelf Life
  • 24 months
  • Preservative
  • Contains no preservative
  • Handling Precautions
  • Cytotoxic handling precautions required
  • HSN Code
  • 30049099
  • USP Compliance
  • Meets USP specifications
  • Compatibility
  • Compatible with DEHP-free infusion sets
  • Route of Administration
  • Intravenous
  • Volume
  • 43.4 ml per vial
  • Available Strengths
  • 30 mg, 100 mg, 260 mg
  • Packaging Type
  • Glass vial
  • Warnings
  • To be administered by healthcare professionals only
  • Dilution
  • Dilute before administration with appropriate IV fluids
 
 

About paclitaxel 260 mg



Experience substantial savings and markdowns on our hot-selling Paclitaxel 260 mg injection, presented in a sublime 43.4 ml USP-compliant glass vial for intravenous use. This exquisite antineoplastic is manufactured to superb standards, offering a clear, colorless to pale yellow solution with no preservative. Carefully balanced at pH 3.0 - 4.0, it is perfect for the treatment of ovarian, breast, and non-small cell lung cancers. The cytotoxic, single-use sterile vial is compatible with DEHP-free infusion sets, and each dose promises excellence in quality and efficacy. Handle with care and entrust only to healthcare professionals.

Advanced Specifications and Versatile Application

Paclitaxel 260 mg stands out with its superb extra features: cytotoxic handling precautions, compatibility with DEHP-free infusion sets, and a shelf life of 24 months. Engineered for sterile, single-use applications, it is specially suitable for oncology suites and chemotherapy centers. This solution is superbly designed for precise dilution before IV administration, making it ideal for both hospital and clinical settings. Its sublime clarity and USP compliance ensure consistent safety and performance, reinforcing trust for healthcare professionals.


Global Reach and Seamless Transaction Assurance

Our main export markets for Paclitaxel 260 mg include dynamic regions across Asia, Africa, and Europe. Orders are processed efficiently to minimize outlay time, and products are expertly packaged in protective glass vials. Detailed export paperwork and secure shipment arrangements ensure each shipment is handed over safely. Sample policies are flexible to customer needs, making order processing straightforward for distributors, exporters, suppliers, and traders. Reliability and superb service are at the heart of our global business model.


FAQ's of paclitaxel 260 mg:


Q: How should Paclitaxel 260 mg be administered?

A: Paclitaxel 260 mg must be diluted with appropriate intravenous fluids before administration and given only through intravenous infusion by qualified healthcare professionals.

Q: What cancers can be treated with Paclitaxel 260 mg?

A: Paclitaxel 260 mg is indicated for use in ovarian cancer, breast cancer, and non-small cell lung cancer as part of comprehensive chemotherapy regimens.

Q: When should cytotoxic handling precautions be observed?

A: Cytotoxic handling precautions are required at every step-during preparation, administration, and disposal-due to the potent antineoplastic nature of Paclitaxel.

Q: Where should Paclitaxel 260 mg vials be stored?

A: The vials should be stored below 25C and protected from light to maintain stability and effectiveness throughout the 24-month shelf life.

Q: What is the process for ordering and receiving samples or bulk shipments?

A: Orders are processed promptly, and packaging is handled with utmost care. Samples and bulk shipments are handed over according to flexible sample policies, with comprehensive export documentation provided.

Q: What are the key features of the packaging and dosage form?

A: Each dose comes in a sterile, single-use glass vial containing a clear, colorless to pale yellow solution, meeting stringent USP compliance and compatible with DEHP-free infusion sets.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Injectables Category

60 Ml Denosumab Solution Injection

60 Ml Denosumab Solution Injection

Price 6000 INR / Piece

Minimum Order Quantity : 1 Piece

Feature : Other, Readytouse prefilled syringe, convenient dosing, preservativefree

Ingredients : Other , Denosumab, excipients, sterile water

Ph Level : Neutral (around pH 6.0) as per formulation standard

Indication : Treatment of osteoporosis, bone loss, and prevention of skeletalrelated events in patients with bone metastases

60 Mg Enoxaparin Sodium Injection IP

60 Mg Enoxaparin Sodium Injection IP

Price 160 INR / Piece

Minimum Order Quantity : 1 Piece

Feature : Other, Prefilled syringe, readytouse, sterile

Ingredients : Other , Enoxaparin Sodium, Water for Injection

Ph Level : 6.0 7.5

Indication : Prevention and treatment of deep vein thrombosis, pulmonary embolism, and other thromboembolic disorders

50 Mg Vinorelbine Injection IP

50 Mg Vinorelbine Injection IP

Price 4499 INR / Vial

Minimum Order Quantity : 1000 Vials

Feature : Other, Singleuse vial, cytotoxic agent

Ingredients : Other , Vinorelbine tartrate and excipients

Ph Level : Approximately 3.5

Indication : Treatment of nonsmall cell lung cancer and advanced breast cancer

cetuximab 100 mg/500 mg

cetuximab 100 mg/500 mg

Price 14000.0 INR / Piece

Minimum Order Quantity : 1 Piece

Feature : Other, Chimeric monoclonal antibody targeting EGFR

Ingredients : Other , Cetuximab, excipients, solvent (sterile water for injection)

Ph Level : 6.8 7.2

Indication : Colorectal cancer, Head and neck cancer



Back to top